(11) 98705-3426
TrademarkIQ íconeTrademarkIQ
Voltar para busca
Dado oficial do USPTO

ONCONIC

Sabia que essa marca já está registrada no Estados Unidos?

Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.

Active USPTO registrationTipo: VerbalEscritório: US

Snapshot rápido

ONCONIC

ST13

US500000079384045

Classe

5, 35

Pedido

79384045

Registro

7592629

Diagnóstico de risco e oportunidade

Leitura executiva para decisão de naming, protocolo e monitoramento.

Atenção: há risco ativo

Situação USPTO

Active USPTO registration

Tipo de processo

Pedido e registro

Eventos registrados

25

Atualização mais recente

03/04/2026

Classificação

Registrada

Tipo de marca

Verbal

Classes Nice

5, 35

Data de depósito

17/10/2023

Data de registro

10/12/2024

Data de expiração

-

Ação recomendada

Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.

Próximo passo

Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.

Dados completos do processo

Campos estruturados da autoridade responsável e do histórico oficial.

Data da situação

10/12/2024

Última transação

03/04/2026

Escritório responsável

United States Patent and Trademark Office

Código da situação

700

Cadastro oficial

Principal Register

Código do desenho

4

Tipo de titular

03

Localização do titular

KR

Examinador

CANTOR, JILLIAN REDDING

Unidade examinadora

M80

Localização atual

FILE REPOSITORY (FRANCONIA)

Titulares e representantes

Titulares

Onconic Therapeutics Inc.

Representantes

John M. Kim IPLA, LLP

Classificação técnica

Classes Nice

Classe 5Classe 35

Códigos Vienna

Sem códigos Vienna disponíveis.

Produtos e serviços

Classe 5

Pharmaceuticals for the treatment of cancer and gastrointestinal diseases; anti-cancer preparations; pharmaceutical agents affecting sensory organs; pharmaceutical agents affecting metabolism; pharmaceutical agents affecting peripheral nervous system; pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations for treatment of immunity system related diseases; pharmaceutical agents affecting digestive organs; cardiovascular treatment preparations; diagnostic biomarker reagents for medical purposes; pharmaceutical preparations for treating respiratory diseases; antibiotic preparations; Veterinary pharmaceutical preparations for the treatment of cancer and gastrointestinal diseases; Veterinary pharmaceutical preparations for the prevention of cancer and gastrointestinal diseases; Medicinal preparations for the treatment of cancer and gastrointestinal diseases; Medicinal herbal preparations; Nutraceuticals for the treatment of cancer and gastrointestinal diseases; Nutraceuticals for use as a dietary supplement; dietary supplements; medicated soap; medical and surgical dressings; preparations of microorganisms for medical or veterinary use

Classe 35

Advertising services; marketing and promotional services; import-export agency services; wholesale store services featuring medical apparatus and instruments; retail store services featuring medical apparatus and instruments; wholesale store services featuring apparatus for drug administration; retail store services featuring apparatus for drug administration; purchasing agency services for pharmaceuticals; wholesale store services featuring pharmaceuticals; retail store services featuring pharmaceuticals; Business intermediary services relating to the matching of buyers and sellers of pharmaceuticals; Procurementpurchasing pharmaceuticals and nutraceutical preparations for therapeutic or medical purposes for others; Procurement servicesprocurement of contracts for others for the purchase of pharmaceuticals and nutraceutical preparations for therapeutic or medical purposes; Arranging of contracts for the purchase and sale of pharmaceuticals and nutraceutical preparations for therapeutic or medical purposesfor others; wholesale store services featuring clinical medical reagents; retail store services featuring clinical medical reagents; wholesale store services featuring nutraceutical preparations for therapeutic or medical purposes; retail store services featuring nutraceutical preparations for therapeutic or medical purposes; sales agency services for nutraceutical preparations for therapeutic or medical purposes; Business electronic data processing services in the field of health care information; administrative management of health care clinics; wholesale store services featuring cosmetics; retail store services featuring cosmetic preparations

Publicações

Histórico de despachos e eventos da marca no USPTO.

25 publicações encontradas

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

06/06/2025

OPNX

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB

17/05/2025

FICS

FINAL DISPOSITION NOTICE SENT TO IB

16/05/2025

FIMP

FINAL DISPOSITION PROCESSED

15/05/2025

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

29/04/2025

OPNR

NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB

29/04/2025

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

10/03/2025

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

10/12/2024

R.PR

REGISTERED-PRINCIPAL REGISTER

10/12/2024

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

08/10/2024

PUBO

PUBLISHED FOR OPPOSITION

08/10/2024

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

18/09/2024

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

04/09/2024

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

31/07/2024

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

31/07/2024

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

31/07/2024

RFNT

REFUSAL PROCESSED BY IB

20/07/2024

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

29/06/2024

RFRR

REFUSAL PROCESSED BY MPU

29/06/2024

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

15/06/2024

CNRT

NON-FINAL ACTION WRITTEN

07/06/2024

DOCK

ASSIGNED TO EXAMINER

03/06/2024

MAFR

APPLICATION FILING RECEIPT MAILED

08/12/2023

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

04/12/2023

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

30/11/2023

Proteção contínua da sua marca

Seja avisado a cada novo depósito que ameace ONCONIC ou a sua marca.

Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.